[1]
Farahani, P. et al. 2018. EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING. Journal of Population Therapeutics and Clinical Pharmacology. 22, 3 (Nov. 2018).